Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Morino, Saori ^a   Kondo, Tatsuya ^a   Sasaki, Kazunari ^a   Adachi, Hironori ^a   Suico, Mary Ann ^a   Sekimoto, Erika ^a   Matsuda, Tomoko ^a   Shuto, Tsuyoshi ^a   Araki, Eiichi ^a   Kai, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INSULIN RECEPTOR SUBSTRATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN 72;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ELECTROSTIMULATION; FAT INTAKE; FATTY LIVER; GLUCOSE BLOOD LEVEL; HEAT SHOCK RESPONSE; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TREATMENT DURATION; ANIMAL; C57BL MOUSE; HYPERGLYCEMIA; LIVER CELL; METABOLISM; MOUSE STRAIN; PHENOTYPE; PHOSPHORYLATION; PHYSIOLOGY;

MUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; ELECTRIC STIMULATION; HEAT-SHOCK RESPONSE; HEPATOCYTES; HSP72 HEAT-SHOCK PROTEINS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 58149177143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004068     Document Type: Article

References (50)

1. Robinson KR (1985) The responses of cells to electrical fields: a review. J Cell Biol 101: 2023-2027.
2. Ainsworth L, Budelier K, Clinesmith M, Fiedler A, Landstrom R, et al. (2006) Transcutaneous electrical nerve stimulation (TENS) reduces chronic hyperalgesia induced by muscle inflammation. Pain 120: 182-187.
3. Nelson FR, Brighton CT, Ryaby J, Simon BJ, Nielson JH, et al. (2003) Use of physical forces in bone healing. J Am Acad Orthop Surg 11: 344-354.
4. Mobbs RJ, Nair S, Blum P (2007) Peripheral nerve stimulation for the treatment of chronic pain. J Clin Neurosci 14: 216-221; discussion 222-213.
5. Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, et al. (2004) Disruption of cancer cell replication by alternating electric fields. Cancer Res 64: 3288-3295.
6. Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, et al. (2007) Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A 104: 10152-10157.
7. Seegers JC, Engelbrecht CA, van Papendorp DH (2001) Activation of signal-transduction mechanisms may underlie the therapeutic effects of an applied electric field. Med Hypotheses 57: 224-230
8. Zhao M, Song B, Pu J, Wada T, Reid B, et al. (2006) Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN. Nature 442: 457-460.
9. Okamoto H, Accili D (2003) In vivo mutagenesis of the insulin receptor. J Biol Chem 278: 28359-28362.
10. Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96.
11. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B 3rd, et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190.
12. White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-422.
13. Ducluzeau PH, Fletcher LM, Welsh GI, Tavare JM (2002) Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles. J Cell Sci 115: 2857-2866.
14. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731.
15. Schinner S, Barthel A, Dellas C, Grzeskowiak R, Sharma SK, et al. (2005) Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. J Biol Chem 280: 7369-7376.
16. Schinner S, Scherbaum WA, Bornstein SR, Barthel A (2005) Molecular mechanisms of insulin resistance. Diabet Med 22: 674-682.
17. Tremblay F, Gagnon A, Veilleux A, Sorisky A, Marette A (2005) Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Endocrinology 146: 1328-1337.
18. Aguirre V, Uchida T, Yenush L, Davis R, White MF (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054.
19. Hilder TL, Tou JC, Grindeland RE, Wade CE, Graves LM (2003) Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle. FEBS Lett 553: 63-67.
20. Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD, et al. (2000) Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem 275: 38088-38094.
21. Volloch V, Mosser DD, Massie B, Sherman MY (1998) Reduced thermo-tolerance in aged cells results from a loss of an hsp72-mediated control of JNK signaling pathway. Cell Stress Chaperones 3: 265-271.
22. Park HS, Lee JS, Huh SH, Seo JS, Choi EJ (2001) Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. Embo J 20: 446-456.
23. McCarty MF (2006) Induction of heat shock proteins may combat insulin resistance. Med Hypotheses 66: 527-534.
24. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, et al. (2008) HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105: 1739-1744.
25. Morino S, Suico MA, Kondo T, Sekimoto E, Yano S, et al. (2008) Mild electrical stimulation increases ubiquitinated proteins and Hsp72 in A549 cells via attenuation of proteasomal degradation. J Pharmacol Sci, In press.
26. Okiyoneda T, Harada K, Takeya M, Yamahira K, Wada I, et al. (2004) Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol Biol Cell 15: 563-574.
27. Shimohara S, Murakami T, Morikawa M, Matsuo J, Nagayama S, et al. (2005) Vitamins K1 and K2 potentiate hyperthermia by down-regulating Hsp72 expression in vitro and in vivo. Int J Oncol 27: 1527-1533.
28. Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, et al. (2006) Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci U S A 103: 12093-12097.
29. Cha DR, Zhang X, Zhang Y, Wu J, Su D, et al. (2007) Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes 56: 2036-2045.
30. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415.
31. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792.
32. Lowell BB, Spiegelman BM (2000) Towards a molecular understanding of adaptive thermogenesis. Nature 404: 652-660.
33. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
34. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, et al. (2004) AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279: 47898-47905.
35. Syed NA, Khandelwal RL (2000) Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells. Mol Cell Biochem 211: 123-136.
36. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A (2003) Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52: 642-649.
37. Farese RV, Sajan MP, Standaert ML (2005) Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp Biol Med (Maywood) 230: 593-605.
38. Gabbay RA, Sutherland C, Gnudi L, Kahn BB, O'Brien RM, et al. (1996) Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 271: 1890-1897.
39. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, et al. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372.
40. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
41. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, et al. (2002) A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
42. Klover PJ, Mooney RA (2004) Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 36: 753-758.
43. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271: 665-668.
44. Shimizu H, Oh IS, Tsuchiya T, Ohtani KI, Okada S, et al. (2006) Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF-alpha levels in Type 2 diabetic patients: a randomized study. Diabet Med 23: 253-257.
45. Kobayashi T, Goto K, Kojima A, Akema T, Uehara K, et al. (2005) Possible role of calcineurin in heating-related increase of rat muscle mass. Biochem Biophys Res Commun 331: 1301-1309.
46. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, et al. (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497.
47. Pethig R, Kell DB (1987) The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology. Phys Med Biol 32: 933-970.
48. Stoy RD, Foster KR, Schwan HP (1982) Dielectric properties of mammalian tissues from 0.1 to 100 MHz: a summary of recent data. Phys Med Biol 27: 501-513.
49. Sekino M, Yamaguchi K, Iriguchi N, Ueno S (2003) Magnetic resonance imaging of convection in an eectrolyte solution and extracellular fluid associated with stationary electric currents. J Applied Physics 94: 5359-5366.
50. McCaig CD, Rajnicek AM, Song B, Zhao M (2005) Controlling cell behavior electrically: current views and future potential. Physiol Rev 85: 943-978.